While most pharma companies have exited the antibiotics area, Japanese drugmaker Shionogi has stuck with it and has just expanded its pipeline with a deal to buy US biotech Qpex Biopharma.

The oral drug Xocova marks the first home-grown medication, developed by Shionogi & Co., which can be prescribed for patients with mild symptoms, suggesting a stable supply of the tablet will be ...

Japan’s Shionogi & Co. Ltd. said its COVID-19 projects in Vietnam are still progressing, after fraud scandals enveloped its partner there and the health ministry. Shionogi is carrying out trials ...